Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

ASTRAZENECA PHARMACEUTICALS LP

Filed by W STRATEGIES, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 18, 2025
Income
$80,000.00
Expenses
Not reported
Filing UUID
68b1b15e-53ff-4cad-9cbb-607db12b08ee
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Implementation of H.R.5376 - Inflation Reduction Act of 2022 and potential reforms involving the treatment of orphan drugs. H.R.946 - ORPHAN Cures Act.

Literal federal measure citations: H.R.5376, H.R.946

HCR · Health Issues

Issues related to insurance coverage of specialty treatments.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.